Chongqing PharscinPharmaceutical Co., Ltd.(abbreviated as "Pharscin Pharma") is acomprehensive pharmaceutical
company with the functions of R&D,manufacturing and sales. The
company focuses on both Chinese and Western medicines. On October
20, 2017, Pharscin Pharma launched its initial public offering of A
shares on Shenzhen Stock Exchange.(Stock code 002907)
The company has 3 wholly owned subsidiaries, namely Chongqing
Pharscin Medicine Co., Ltd., Chongqing Pharscin Pharmacy Retail
Chain Co., Ltd. and Chongqing Pharscin Biotech Co., Ltd.